Bavarian Nordic — Juli 2022
-
@Worktrader Enig, det lyder som en god strategi. Jeg har bare ikke flere frie midler lige nu til at fylde op med - så hvis jeg skal udnytte dips, skal jeg sælge en klump på toppen. Det er jeg så bare blevet meget påpasselig med for tiden, så jeg gik også glip af muligheden her til morgen...
-
@CSørensen 10:51 370,50 (+5,29% ift købt i mandags) dog ikke mit "rugbrød", men dem jeg leger med... købte ind igen ved 363,50, så det var nok lidt tidligt...
-
https://www.youtube.com/watch?v=91zcY_PTZ3s MSNBC The Mehdi Hansen Show hele 15 min forbeholdt orientering om MPX - God info om håndteringen / fordomme / politisering / socioøkonomisk konsekvenser af MPX - der er pres på i U.S.A... Kan også blot lyttes til
-
Aktier/middag: Nyt fra USA sender grønne aktier op - Mærsk følger med
https://www.proinvestor.com/investornyt/856998/aktier-middag-nyt-fra-usa-sender-gronne-aktier-op-maersk-folger-med -
https://www.youtube.com/watch?v=kwQsbhlyrvw fra i går "WHO Media briefing on monkeypox, COVID-19 + other global health issues". 1 time primært om MPX + enormt meget om vacciner og spørgsmål hertil. Tror @CSørensen har linket til/ omtalt før, men har selv først fået lyttet til hele udsendelsen nu. Der er godt nok MEGEN forbehold hos panelet om BAVAs vaccine... Manglende dokumention om effektivitet bliver hamret hjem igen og igen. Nok en gang: god som baggrunds-"radio" for de, der ikke kan få nok.
-
@Cupcake 11:54 Har ikke selv hørt hele udsendelsen, men skal måske gøre det. Ærgerligt, at BAVA ikke har testet efficacy i Afrika. Men jeg forstår det sådan, at der arbejdes intenst på at indsamle data, og at man forventer en virkningsgrad på ca. 85 % baseret på erfaringer med almindelig koppevirus - har I også forstået det sådan?
-
https://healthpolicy-watch.news/monkeypox-vaccine-doses-high-risk-groups/ World Needs 180,000 – 360,000 Monkeypox Vaccine Doses For People Exposed – Up to 10 million for High Risk Groups - meget interessant artikel, synes jeg.
-
4 Things to Know About the Company Making the Monkeypox Vaccine https://www.barrons.com/amp/articles/bavarian-nordic-monkeypox-vaccine-51658856060
-
- Jynneos Will Likely Remain the Dominant Vaccine
Bavarian’s monkeypox vaccine is a non-replicating live virus vaccine; it uses a modified version of a virus of the same family as monkeypox to train the immune system to fight monkeypox and smallpox infections. It represents an advance over earlier smallpox and monkeypox vaccines, such as Emergent Biosolutions ‘ (EBS) ACAM2000, which contains a replicating live virus and carried a number of safety risks.
- Jynneos Will Likely Remain the Dominant Vaccine
-
- European Countries Don’t Have a Jynneos Stockpile
The U.S. has been buying doses of Jynneos since 2003 for its Strategic National Stockpile, which holds vaccine doses in case of emergencies.
Bavarian Nordic says it sold the U.S. 30 million doses before 2019, all of which are now expired.
- European Countries Don’t Have a Jynneos Stockpile
-
Peaker expects EU countries will stockpile for future smallpox and monkeypox outbreaks. He said he expects those efforts to bring in 70 million orders over the next four years, for a total of $5.6 billion in sales.
-
- Bavarian Nordic’s Factory Is Offline
In a bit of epically bad luck, Bavarian Nordic’s bulk manufacturing facility was shut down for expansion when the monkeypox outbreak hit in the spring. The company has said it expects the factory to reopen it in August, but that it will take another six months for new bulk material to be ready.
- Bavarian Nordic’s Factory Is Offline
-
- It’s Unclear How Widespread Vaccine Usage Will Be
The Centers for Disease Control and Prevention has reported 3,487 monkeypox cases in the U.S. so far. The U.S. has shipped 310,385 Jynneos doses to state public health authorities amid the current outbreak. That comes after a shift in the U.S. strategy announced in late June, which dramatically expanded eligibility for the vaccines.
- It’s Unclear How Widespread Vaccine Usage Will Be
-
@Cubinvest2021. Har du har et større indlæg, så kan du med fordel starte et "debat"-indlæg i stedet og smide et link her i chatten. Dit budskab er det sammen, men du udnytter hjemmesidens funktion bedre og sætter ikke en prop i debatten.
-
prob i chatten (ej debatten...)
-
Du er meget velkommen til, at lave et debatindlæg @Cubinvest2021
-
...men hvis man rejser, eller er på farten, så kan nemt glippe 'debatten' hvis man bare har chatten åben (som mig)...så personligt er jeg klart tilhænger af at poste det her
Ja, jeg er nok en smule hooked lige nu - men det er også sjovt (for det meste)..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind